Clincosm LogoSign in Get a demo

HIV Infections

Showing NaN - NaN of 505
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in Puerto Rico, United States (VH3810109, Cabotegravir, Standard of care (SOC))

Not yet recruiting
  • HIV Infections
  • VH3810109
  • +3 more
  • Birmingham, Alabama
  • +42 more
Aug 9, 2023

HIV Trial in South Africa, United States (sD-NP-GT8 DNA, IL-12 DNA, Trimer 4571)

Not yet recruiting
  • HIV Infections
  • sD-NP-GT8 DNA
  • +4 more
  • Birmingham, Alabama
  • +5 more
Mar 10, 2023

HIV Trial in Worldwide (Oral Cabotegravir (CAB), Oral Rilpivirine (RPV), Long-Acting Injectable Cabotegravir (CAB LA))

Recruiting
  • HIV Infections
  • Oral Cabotegravir (CAB)
  • +4 more
  • La Jolla, California
  • +30 more
Feb 2, 2023

HIV Trial in United States (BG505 MD39.3 mRNA, BG505 MD39.3 gp151 mRNA, BG505 MD39.3 gp151 CD4KO mRNA)

Suspended
  • HIV Infections
  • BG505 MD39.3 mRNA
  • +2 more
  • Birmingham, Alabama
  • +9 more
Feb 1, 2023

Study of Multidrug-Resistant Patient Outcomes With and Without

Recruiting
  • HIV Infections
  • Multi-Antiviral Resistance
  • No ibalizumab or Pre-ibalizumab treatment
  • On ibalizumab treatment
  • Los Angeles, California
  • +38 more
Jan 31, 2023

NAFLD, NASH - Nonalcoholic Steatohepatitis, HIV Trial in Indianapolis, Boston (Vitamin E, Placebos)

Active, not recruiting
  • NAFLD
  • +2 more
  • Vitamin E
  • Placebos
  • Indianapolis, Indiana
  • +1 more
Feb 1, 2023

Hepatitis B, HIV Trial in Worldwide (Selgantolimod, Placebo)

Recruiting
  • Hepatitis B
  • HIV Infections
  • San Diego, California
  • +35 more
Jan 31, 2023

HIV Trial in Worldwide (Cabotegravir Tablets, Cabotegravir Injectable Suspension (CAB LA), Rilpivirine Tablets)

Active, not recruiting
  • HIV Infections
  • Cabotegravir Tablets
  • +4 more
  • Bakersfield, California
  • +116 more
Jan 22, 2023

HIV, Substance Use, Adherence, Medication Trial in Boston (Descovy or Truvada, ID-Cap System, Beiwe)

Recruiting
  • HIV Infections
  • +3 more
  • Descovy or Truvada
  • +2 more
  • Boston, Massachusetts
    Fenway Health
Dec 20, 2022

Hepatitis C, HIV, Opioid-use Disorder Trial in Boston (PRC brief motivational interview intervention, Phone contact)

Completed
Has Results
  • Hepatitis C
  • +2 more
  • PRC brief motivational interview intervention
  • Phone contact
  • Boston, Massachusetts
    Boston Medical Center - Low-Barrier-Access (LBA) walk-in clinic
Nov 18, 2022

Consent for Use of Stored Patient Specimens for Future Testing

Recruiting
  • HIV Infections
    • Los Angeles, California
    • +62 more
    Dec 7, 2022

    HIV Trial in United States (APRETUDE, Cabotegravir OLI)

    Recruiting
    • HIV Infections
    • Los Angeles, California
    • +16 more
    Oct 24, 2022

    HIV Trial in Boston (TRUVADA + raltegravir)

    Completed
    Has Results
    • HIV Infections
    • TRUVADA + Raltegravir
    • Boston, Massachusetts
      Fenway Community Health
    Oct 4, 2022

    HIV Trial in South Africa, Thailand, United States (Doravirine (DOR), Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate

    Completed
    Has Results
    • HIV Infections
    • Doravirine (DOR)
    • +2 more
    • Aurora, Colorado
    • +7 more
    Sep 30, 2022

    Lipodystrophy, HIV Trial in Worldwide (Tesamorelin, Placebo for Tesamorelin)

    Completed
    Has Results
    • Lipodystrophy
    • HIV Infections
    • Birmingham, Alabama
    • +46 more
    Sep 16, 2022

    Acquired Immune Deficiency Syndrome (AIDS), HIV Trial in Worldwide (ATV, DRV, Cobicistat)

    Recruiting
    • Acquired Immune Deficiency Syndrome (AIDS)
    • HIV Infections
    • Long Beach, California
    • +29 more
    Aug 18, 2022

    Antiretroviral Drugs and Related Drugs During and After

    Completed
    Has Results
    • HIV Infections
    • Birmingham, Alabama
    • +61 more
    Jun 28, 2022

    HIV Trial in United States (MPER-656 Liposome Vaccine, Placebo for MPER-656 Liposome Vaccine)

    Completed
    Has Results
    • HIV Infections
    • MPER-656 Liposome Vaccine
    • Placebo for MPER-656 Liposome Vaccine
    • Birmingham, Alabama
    • +5 more
    Jun 15, 2022

    Cytomegalovirus Infections, HIV, Vaccine Trial in United States (CMV-MVA Triplex, Placebo)

    Recruiting
    • Cytomegalovirus Infections
    • +2 more
    • CMV-MVA Triplex
    • Placebo
    • Birmingham, Alabama
    • +11 more
    Jun 20, 2022

    HIV, Cytomegalovirus, CMV Trial in United States (Letermovir 240 MG Oral Tablet, Letermovir 480 MG Oral Tablet, Combination ART)

    Recruiting
    • HIV Infections
    • +2 more
    • Letermovir 240 MG Oral Tablet
    • +2 more
    • Birmingham, Alabama
    • +18 more
    Jun 20, 2022

    HIV Trial in Boston (env (A,B,C,A/E)/gag (C) DNA Vaccine, gp120 (A,B,C,A/E) Protein Vaccine, GLA-SE adjuvant)

    Active, not recruiting
    • HIV Infections
    • env (A,B,C,A/E)/gag (C) DNA Vaccine
    • +3 more
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jun 8, 2022

    HIV Trial in Boston, Seattle, Nairobi (BG505 SOSIP.664 gp140, adjuvanted, Placebo)

    Active, not recruiting
    • HIV Infections
    • BG505 SOSIP.664 gp140, adjuvanted
    • Placebo
    • Boston, Massachusetts
    • +2 more
    May 6, 2022

    HIV Trial in Switzerland, United States (VRC07-523LS, Placebo)

    Completed
    Has Results
    • HIV Infections
    • VRC07-523LS
    • Placebo
    • Birmingham, Alabama
    • +6 more
    Feb 21, 2022

    HIV Trial in Boston (CAB-RPV LA, Standard treatment within an HIV clinic)

    Enrolling by invitation
    • HIV Infections
    • CAB-RPV LA
    • Standard treatment within an HIV clinic
    • Boston, Massachusetts
    • +1 more
    Feb 24, 2022

    HIV Trial in Boston, Seattle (VRC07-523LS)

    Completed
    Has Results
    • HIV Infections
    • VRC07-523LS
    • Boston, Massachusetts
    • +1 more
    Mar 4, 2022